Cargando…

Interleukin-6-to-Albumin Ratio as a Superior Predictor of Mortality in End-Stage Kidney Disease Patients

INTRODUCTION: In patients with chronic kidney disease (CKD), high interleukin-6 (IL-6) and low albumin circulating concentrations are associated with worse outcomes. We examined the IL-6-to-albumin ratio (IAR) as a predictor of risk of death in incident dialysis patients. METHODS: In 428 incident di...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiejia, Qureshi, Abdul Rashid, Suliman, Mohamed E., Heimbürger, Olof, Barany, Peter, Stenvinkel, Peter, Lindholm, Bengt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10623391/
https://www.ncbi.nlm.nih.gov/pubmed/37231796
http://dx.doi.org/10.1159/000531191
_version_ 1785130731451711488
author Li, Xiejia
Qureshi, Abdul Rashid
Suliman, Mohamed E.
Heimbürger, Olof
Barany, Peter
Stenvinkel, Peter
Lindholm, Bengt
author_facet Li, Xiejia
Qureshi, Abdul Rashid
Suliman, Mohamed E.
Heimbürger, Olof
Barany, Peter
Stenvinkel, Peter
Lindholm, Bengt
author_sort Li, Xiejia
collection PubMed
description INTRODUCTION: In patients with chronic kidney disease (CKD), high interleukin-6 (IL-6) and low albumin circulating concentrations are associated with worse outcomes. We examined the IL-6-to-albumin ratio (IAR) as a predictor of risk of death in incident dialysis patients. METHODS: In 428 incident dialysis patients (median age 56 years, 62% men, 31% diabetes mellitus, 38% cardiovascular disease [CVD]), plasma IL-6 and albumin were measured at baseline to calculate IAR. We compared the discrimination of IAR with other risk factors for predicting 60-month mortality using receiver operating characteristic curve (ROC) and analyzed the association of IAR with mortality using Cox regression analysis. We divided patients into IAR tertiles and analyzed: (1) cumulative incidence of mortality and the association of IAR with mortality risk in Fine-Gray analysis, taking kidney transplantation as competing risk and (2) the restricted mean survival time (RMST) to 60-month mortality and differences of RMST (∆RMST) between IAR tertiles to describe quantitative differences of survival time. RESULTS: For all-cause mortality, the area under the ROC curve (AUC) for IAR was 0.700, which was greater than for IL-6 and albumin separately, while for CV mortality, the AUC for IAR (0.658) showed negligible improvement over IL-6 and albumin separately. In Cox regression analysis, IAR was significantly associated with all-cause mortality but not with CV mortality. Both high versus low and middle versus low tertiles of IAR associated with higher risk of all-cause mortality, subdistribution hazard ratio of 2.22 (95% CI 1.40–3.52) and 1.85 (95% CI 1.16–2.95), respectively, after adjusting for age, sex, diabetes mellitus, CVD, smoking, and estimated glomerular filtration rate. ∆RMST at 60 months showed significantly shorter survival time in middle and high IAR tertiles compared with low IAR tertile for all-cause mortality. CONCLUSIONS: Higher IAR was independently associated with significantly higher all-cause mortality risk in incident dialysis patients. These results suggest that IAR may provide useful prognostic information in patients with CKD.
format Online
Article
Text
id pubmed-10623391
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-106233912023-11-04 Interleukin-6-to-Albumin Ratio as a Superior Predictor of Mortality in End-Stage Kidney Disease Patients Li, Xiejia Qureshi, Abdul Rashid Suliman, Mohamed E. Heimbürger, Olof Barany, Peter Stenvinkel, Peter Lindholm, Bengt Am J Nephrol Patient-Oriented, Translational Research: Research Article INTRODUCTION: In patients with chronic kidney disease (CKD), high interleukin-6 (IL-6) and low albumin circulating concentrations are associated with worse outcomes. We examined the IL-6-to-albumin ratio (IAR) as a predictor of risk of death in incident dialysis patients. METHODS: In 428 incident dialysis patients (median age 56 years, 62% men, 31% diabetes mellitus, 38% cardiovascular disease [CVD]), plasma IL-6 and albumin were measured at baseline to calculate IAR. We compared the discrimination of IAR with other risk factors for predicting 60-month mortality using receiver operating characteristic curve (ROC) and analyzed the association of IAR with mortality using Cox regression analysis. We divided patients into IAR tertiles and analyzed: (1) cumulative incidence of mortality and the association of IAR with mortality risk in Fine-Gray analysis, taking kidney transplantation as competing risk and (2) the restricted mean survival time (RMST) to 60-month mortality and differences of RMST (∆RMST) between IAR tertiles to describe quantitative differences of survival time. RESULTS: For all-cause mortality, the area under the ROC curve (AUC) for IAR was 0.700, which was greater than for IL-6 and albumin separately, while for CV mortality, the AUC for IAR (0.658) showed negligible improvement over IL-6 and albumin separately. In Cox regression analysis, IAR was significantly associated with all-cause mortality but not with CV mortality. Both high versus low and middle versus low tertiles of IAR associated with higher risk of all-cause mortality, subdistribution hazard ratio of 2.22 (95% CI 1.40–3.52) and 1.85 (95% CI 1.16–2.95), respectively, after adjusting for age, sex, diabetes mellitus, CVD, smoking, and estimated glomerular filtration rate. ∆RMST at 60 months showed significantly shorter survival time in middle and high IAR tertiles compared with low IAR tertile for all-cause mortality. CONCLUSIONS: Higher IAR was independently associated with significantly higher all-cause mortality risk in incident dialysis patients. These results suggest that IAR may provide useful prognostic information in patients with CKD. S. Karger AG 2023-05-24 2023-11 /pmc/articles/PMC10623391/ /pubmed/37231796 http://dx.doi.org/10.1159/000531191 Text en © 2023 The Author(s). Published by S. Karger AG, Basel https://creativecommons.org/licenses/by-nc/4.0/This article is licensed under the Creative Commons Attribution 4.0 International License (CC BY) (http://www.karger.com/Services/OpenAccessLicense). Usage, derivative works and distribution are permitted provided that proper credit is given to the author and the original publisher.
spellingShingle Patient-Oriented, Translational Research: Research Article
Li, Xiejia
Qureshi, Abdul Rashid
Suliman, Mohamed E.
Heimbürger, Olof
Barany, Peter
Stenvinkel, Peter
Lindholm, Bengt
Interleukin-6-to-Albumin Ratio as a Superior Predictor of Mortality in End-Stage Kidney Disease Patients
title Interleukin-6-to-Albumin Ratio as a Superior Predictor of Mortality in End-Stage Kidney Disease Patients
title_full Interleukin-6-to-Albumin Ratio as a Superior Predictor of Mortality in End-Stage Kidney Disease Patients
title_fullStr Interleukin-6-to-Albumin Ratio as a Superior Predictor of Mortality in End-Stage Kidney Disease Patients
title_full_unstemmed Interleukin-6-to-Albumin Ratio as a Superior Predictor of Mortality in End-Stage Kidney Disease Patients
title_short Interleukin-6-to-Albumin Ratio as a Superior Predictor of Mortality in End-Stage Kidney Disease Patients
title_sort interleukin-6-to-albumin ratio as a superior predictor of mortality in end-stage kidney disease patients
topic Patient-Oriented, Translational Research: Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10623391/
https://www.ncbi.nlm.nih.gov/pubmed/37231796
http://dx.doi.org/10.1159/000531191
work_keys_str_mv AT lixiejia interleukin6toalbuminratioasasuperiorpredictorofmortalityinendstagekidneydiseasepatients
AT qureshiabdulrashid interleukin6toalbuminratioasasuperiorpredictorofmortalityinendstagekidneydiseasepatients
AT sulimanmohamede interleukin6toalbuminratioasasuperiorpredictorofmortalityinendstagekidneydiseasepatients
AT heimburgerolof interleukin6toalbuminratioasasuperiorpredictorofmortalityinendstagekidneydiseasepatients
AT baranypeter interleukin6toalbuminratioasasuperiorpredictorofmortalityinendstagekidneydiseasepatients
AT stenvinkelpeter interleukin6toalbuminratioasasuperiorpredictorofmortalityinendstagekidneydiseasepatients
AT lindholmbengt interleukin6toalbuminratioasasuperiorpredictorofmortalityinendstagekidneydiseasepatients